Talking about what others are afraid to say
We like to talk about breakthroughs in oncology—immunotherapy, targeted therapies, precision medicine, antibody-drug conjugates, and new combinations that can extend lives. Cancer has always been frightening because of what it …
How Many of Us Can Actually Afford Cancer Care? Read More
American health care has created an impressive business model: We refer to the customer as a patient. And that makes all the difference.
Health System Profits Are Increasingly Coming at the Expense of Patients Read More
Walk into any major pharmaceutical conference—whether it’s ISPE, Pharma 4.0, or the countless regulatory affairs summits—and you’ll hear the same familiar refrains echoing through convention halls year after year. Supply …
The Pharma Conference Groundhog Day: Why Patient Outcomes Are the Financial Strategy We’re Ignoring Read More
There’s no denying the transformative potential of GLP-1 drugs like semaglutide and tirzepatide. For many obese patients, these medications have offered something that diet and exercise alone rarely deliver—substantial and …
The GLP-1 Dilemma: Are We Ignoring the Long-Term Risks? Read More
Albert Bourla, CEO of Pfizer, recently suggested that former President Donald Trump should be considered for a Nobel Peace Prize for his role in Operation Warp Speed and the development …
How Pfizer CEO’s Nobel Praise for Trump Misses its Mark Read More
For all the talk about “omnichannel” and “patient-centricity,” pharma marketers continue to drop the ball where it matters most: the product website. Despite being the most controllable and brand-owned digital asset, …
Why Your Pharma Website Isn’t Connecting With Patients Read More
The U.S. healthcare system is undergoing a transformation that’s leaving many patients feeling confused, abandoned, and increasingly on their own. Doctor appointments are rushed. Insurance hurdles delay care. Health information …
Building Trust in Healthcare: Pharma’s New Role Read More
With Robert F. Kennedy Jr. at the helm of the Department of Health and Human Services, there is a concern that the government may inadvertently become a conduit for health …
Robert F. Kennedy Jr.: Concerns Over Health Misinformation Read More